Search Site

TAQA Q1 net income $571m

Net income fell $2.58bn due to one-off items recognized in 2023.

QatarEnergy buys stake in Egypt blocks

It did not disclose the cost of the agreement.

TSMC’s April revenue up 60%

It capitalized on huge wave of demand for chips used in AI hardware.

Etihad reports record Q1 profit

Total revenue increased by $269 million in the same period.

Aramco Q1 profit down 14.5%

Despite lower profit, it will pay $31bn in dividends to Saudi government.

SPIMACO secures $335m loan

Set up in 1986, the pharma company is one of the biggest players in the Saudi medical sector. (SPIMACO)
  • The pharma company secured the shariah-compliant financing to grow the business
  • The firm obtained the facilities in the form of short-term loans to finance working capital needs, long-term loans for expansions and investments, and treasury facilities

Riyadh, Saudi Arabia— Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) has obtained a loan of $335 million from Bank Albilad, Gulf International Bank, and Banque Saudi Fransi.

The pharma company secured the shariah-compliant financing to grow the business.

The firm obtained the facilities in the form of short-term loans to finance working capital needs, long-term loans for expansions and investments, and treasury facilities, according to a bourse filing.

Bank Albilad, Gulf International Bank, and Banque Saudi Fransi were the sole financing entities of the transaction.

Established in 1986, SPIMACO is one of the biggest players in the Saudi medical sector, engaged in manufacturing and distributing pharmaceutical products and medical appliances.